More than 13mn people in Africa could catch malaria owing to proposed US cuts - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
疾病预防和控制

More than 13mn people in Africa could catch malaria owing to proposed US cuts

Lancet study underscores fears over potential impact of President Trump’s plan to nearly halve funding in 2025

US plans to slash spending on a flagship campaign against malaria threaten millions more cases and tens of thousands of extra deaths in Africa this year, according to new research on the potential impact of global aid cuts.    

Scientists project that full funding of the President’s Malaria Initiative (PMI) would stop more than 13mn people on the continent contracting the mosquito-borne disease in 2025, but Donald Trump’s administration proposes to nearly halve its budget.

The study published in The Lancet underscores fears over the impact on global health of steep cuts to development assistance by Washington and some European capitals.

“International aid budgets are under increasing pressure and difficult decisions must be made to protect the progress that has been made,” said Peter Gething, the research’s senior author and co-head of the Malaria Atlas Project at The Kids Research Institute Australia.

“At full strength, we estimated that PMI could prevent nearly 14mn malaria cases and save more than 100,000 lives in Africa this year, by protecting vulnerable populations with bed nets, insecticidal spraying and antimalarial drugs.”

The PMI, which was launched 20 years ago under President George W Bush, has invested more than $9bn via the US Agency for International Development.

Congress appropriated about $800mn for it last year alone, but the Trump administration proposes to cut its annual budget by 47 per cent.

The Lancet study looks at projected contributions of a fully-funded PMI to crucial malaria control measures, such as insecticide treatment of bed nets, preventive medication for children at the height of the malaria season, and routine treatment.

It found the PMI would account for a big part of the total malaria response in 27 African countries this year, averting an estimated 11.3 per cent of cases and 37.5 per cent of deaths that would have occurred otherwise.

International efforts have helped significantly reduce deaths from malaria, although children under the age of five still account for three-quarters of deaths in Africa.

There were 263mn cases of the disease and just under 600,000 deaths from it worldwide in 2023. An estimated 2.2bn cases of malaria and 12.7 million deaths have been averted by interventions since 2000, according to the World Health Organization.

The proposed cuts to the PMI would be “devastating”, said Martin Edlund, chief executive of Malaria No More, a non-profit group campaigning to eradicate the disease.

“It would . . . reverse hard-won progress, hinder the rollout of new innovations, like breakthrough vaccines, and risk dangerous malaria outbreaks in vulnerable regions,” Edlund said. “By fighting malaria, the US promotes regional stability, advances American interests abroad, and strengthens its soft power.”

The Global Fund to Fight Aids, Tuberculosis and Malaria, which relies on the US for a third of its resources, urged the Trump administration to continue the PMI’s long-running support for efforts to tackle the disease.

“Together, PMI and the Global Fund account for 93 per cent of external financing for malaria — a vital lifeline for countries with limited fiscal space,” said Peter Sands, the fund’s executive director.

“Domestic investments are growing, and malaria programmes are strengthening health systems — but global solidarity remains essential to avoid losing ground.”

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
2天前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。
设置字号×
最小
较小
默认
较大
最大
分享×